
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
MUMBAI: India’s Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-denominated debt sale to partly fund a bridge loan it took to acquire US healthcare firm Organon & Co., three sources said on Tuesday.

































.jpg)




.jpg)
.jpg)








.jpg)



























_20260909054021554_9b5681.webp)





